Cell therapy in the treatment of non-healing trophic ulcers of the lower extremities

Gilevich I.V.; Shubrov E.N.; Bogdanov S.B.; Fedyushkin V.V.; Kolomiytseva E.A.; Shubrova V.V.

doi:https://doi.org/10.17116/plast.hirurgia202003153

Gilevich I.V.

Research Institution — Regional Clinical Hospital No.1

Shubrov E.N.

Research Institution — Regional Clinical Hospital No.1

Bogdanov S.B.

Kuban State Medical University;
Research Institute — Ochapovsky Regional Clinical Hospital No. 1

Fedyushkin V.V.

Research Institution — Regional Clinical Hospital No.1

Kolomiytseva E.A.

Research Institution — Regional Clinical Hospital No.1

Shubrova V.V.

Research Institution — Regional Clinical Hospital No.1

Cell therapy in the treatment of non-healing trophic ulcers of the lower extremities

Authors:

Gilevich I.V., Shubrov E.N., Bogdanov S.B., Fedyushkin V.V., Kolomiytseva E.A., Shubrova V.V.

More about the authors

Journal: Plastic Surgery and Aesthetic Medicine. 2020;(3): 53‑59

DOI: 10.17116/plast.hirurgia202003153

Read: 2393 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gilevich IV, Shubrov EN, Bogdanov SB, Fedyushkin VV, Kolomiytseva EA, Shubrova VV. Cell therapy in the treatment of non-healing trophic ulcers of the lower extremities. Plastic Surgery and Aesthetic Medicine. 2020;(3):53‑59. (In Russ.)
https://doi.org/10.17116/plast.hirurgia202003153

Подписка 2026 Пластическая хирургия и эстетическая медицина (Plastic Surgery and Aesthetic Medicine)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the effectiveness of allogeneic fibroblasts in the treatment of chronic trophic ulcers of the lower extremities.

MATERIAL AND METHODS

Treatment of 3 patients with chronic ulcers of lower extremities was analyzed. Allogeneic fibroblasts were obtained from the cell bank.

RESULTS

Allogeneic fibroblasts improved the engraftment of an autologous skin graft in patients with large trophic ulcers of the lower extremities after previous unsuccessful standard therapy including vacuum therapy. Skin autoplasty was failed too. Allogeneic fibroblasts were used before plastic closure of the wound with a split-thickness skin autograft. Complete adaptation of the skin graft was observed after 14—15 days. Thus, this technique made it possible to reduce the time of graft healing by 5—7 days. In one case, skin autoplasty with partial adaptation of the flap and formation of several skin fistulous pathways were performed with high risk of limb amputation. Application of allogeneic fibroblasts ensured wound healing and preservation of the remaining skin flap. No amputations were required.

CONCLUSION

Allogeneic human fibroblasts together with autologous dermoplasty stimulates epithelization and reduces the risk of complications in patients with chronic ulcers of lower extremities.

Keywords:

trophic ulcer

autodermoplasty

dermal fibroblasts

cell therapy

Authors:

Gilevich I.V.

Research Institution — Regional Clinical Hospital No.1

Shubrov E.N.

Research Institution — Regional Clinical Hospital No.1

Bogdanov S.B.

Kuban State Medical University;
Research Institute — Ochapovsky Regional Clinical Hospital No. 1

Fedyushkin V.V.

Research Institution — Regional Clinical Hospital No.1

Kolomiytseva E.A.

Research Institution — Regional Clinical Hospital No.1

Shubrova V.V.

Research Institution — Regional Clinical Hospital No.1

Received:

17.05.2020

Accepted:

27.05.2020

Close metadata

References:

Nilforoushzadeh MA, Ashtiani HRA, Nickhah N, Fard M, Mahmoudbeyk M, Jahangiri F, Ansari ZJ, Zare S. Application of dermal fibroblast cells in cell therapy of wound. Journal of Skin and Stem Cell. 2017;4(3-4):e69092. https://doi.org/10.5812/jssc.69092
Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC, Longaker MT. Human skin wounds: a major and snowballing threat to public health and the economy. Wound repair and regeneration, 2009;17(6):763-771. https://doi.org/10.1111/j.1524-475X.2009.00543.x
Gould L, Abadir P, Brem H, Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney JA, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen. 2015;23(1):1-13. https://doi.org/10.1111/jgs.13332
Galstyan GR, Tokmakova AYu, Egorova DN, Mitish VA, Paskhalova YuS, Antsiferov MB, Komelyagina EYu, Udovichenko OV, Gur’eva IV, Bregovskiy VB, Eroshkin IA, Eroshenko AnV, Eroshenko AlV. Clinical guidelines for diagnosis and treatment of diabetic foot syndrome. Wounds and wound infections. 2015;3:60-81. (In Russ.).
Xie T, Ye J, Rerkasem K, Mani R. The venous ulcer continues to be a clinical challenge: an update. Burns Trauma. 2018;6:18. https://doi.org/10.1186/s41038-018-0119-y
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;1 38:271-281. https://doi.org/10.1016/j.diabres.2018.02.023
Lopes L, Setia O, Aurshina A, Liu S, Hu H, Isaji T, Liu H, Wang T, Ono S, Guo X, Yatsula B, Guo J, Gu Y, Navarro T, Dardik A. Stem cell therapy for diabetic foot ulcers: areview of preclinical and clinical research. Stem Cell Res Ther. 2018;9(1):188. https://doi.org/10.1186/s13287-018-0938-6
Reeder S, de Roos KP, de Maeseneer M, Sommer A, Neumann HAM. Ulcer recurrence after in-hospital treatment for recalcitrant venous leg ulceration. Br J Dermatol. 2013;168(5):999-1002. https://doi.org/10.1111/bjd.12164
Karapetyan GE, Yakimov SV, Mikitin IL, Kochetova LV, Pahomova RA. Modern method of maintaining trophic ulcers. Fundametal research. 2013; 9:1017-1018. (In Russ.).
Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol. 1998;111(5):850-857. https://doi.org/10.1046/j.1523-1747.1998.00381.x
Zhang Y, Deng H, Tang Z. Efficacy of cellular therapy for diabetic foot ulcer: a meta-analysis of randomized controlled clinical trials. Cell transplantation. 2017;26(12):1931-1939. https://doi.org/10.1177/0963689717738013
Tkachenko AN, Zharkov AV, Antonov DV, Kovalenko AV, Rusakevich KI. Amputations of the lower extremities in elderly and senile patients with obliterating atherosclerosis. Vestnik Sankt-Peterburgskogo universiteta. Medicina. 2011;1(11):135-142. (In Russ.).
Dudanov I.P. Kriticheskaja ishemija nizhnih konechnostej v preklonnom i starcheskom vozraste. Monografija. Petrozavodsk: Izd-voPetrGU; 2009. (In Russ.).
Carducci M, Bozzetti M, Spezia M, Ripamonti G, Saglietti G. Treatment of a refractory skin ulcer using punch graft and autologous platelet-rich plasma. Case Rep Dermatol Med. 2016;2016:7685939. https://doi.org/10.1155/2016/7685939
Tuganbekov TU, Askarov MB, Ashimov NT, Sajpieva DT. Stem Cells Therapy of Lower Extremity Ulcers. Klinicheskaja medicina Kazahstana. 2013; 4(30):14-20. (In Russ.).
Bogdan VG, Tolstov DA. Clinical efficacy autodermoplasty using platelet-rich autoplasma at plastic closure of trophic ulcers of venous etiology large size Voennaja medicina. 2015;2:65-69. (In Russ.).
Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther. 2014;31:817-836. https://doi.org/10.1007/s12325-014-0140-x
Dalla LP, Cogo A, Deanesi W, Stocchiero C, Colletta VC. Using hyaluronic acid derivatives and cultured autologous fibroblasts and keratinocytes in a lower limb wound in a patient with diabetes: a case report. Ostomy Wound Manage. 2002;48(9):46-49.
Porhanov VA, Bogdanov SB, Gilevich IV, Fedorenko TV, Kolomijceva EA, Bogdanova YuA. New approaches for full-thickness grafting of the face. Pediatric Traumatology, Orthopaedics and Reconstructive Surgery. 2017;5(4):68-73. (In Russ.). https://doi.org/10.17816/PTORS5468-73
Qadura M, Terenzi DC, Verma S, Al-Omran M, Hess DA. Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies. Stem Cells. 2018;36(2):161-171. https://doi.org/10.1002/stem.2751
Gould L, Abadir P, Brem H. et al. Chronic wound repair and healing in older adults: Current status and future research. Wound Repair Regen. 2015; 23(1):1-13. https://doi.org/10.1111/wrr.12245
Gilevich IV, Fedorenko TV, Kolomiytceva EA, Bogdanov SB, Semenchenko AA, Ivashchuk YuV. Advances in cell therapy of burns: a review of literature and case reports Innovacionnaja medicina Kubani. 2017;6(2):6-14. (In Russ.).
Alekseev AA, Salakhiddinov KZ, Gavrilyuk BK, Tyurnikov YuI. Complex treatment of deep burns on basis of surgical necrectomies and modern biotechnological methods. Annaly hirurgii. 2012;6:41-45. (In Russ.).
Moustafa M, Simpson C, Glover M, Dawson RA, Tesfaye S, Creagh FM, Haddow D, Short R, Heller S, MacNeil S. A new autologous keratinocyte dressing treatment for nonhealing diabetic neuropathic foot ulcers. Diabet Med. 2004;21(7):786-789. https://doi.org/10.1111/j.1464-5491.2004.01166.x
Ozer K, Colak O. Leucocyte- and platelet-rich fibrin as a rescue therapy for small-to-medium-sized complex wounds of the lower extremities. Burns Trauma. 2019;7:11. https://doi.org/10.1186/s41038-019-0149-0
Cho JW, Kim SA, Lee KS. Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. Int J Mol Med. 2012;29:32-36. https://doi.org/10.3892/ijmm.2011.803